Birth control

Birth control is voluntary method of fertility control of the number of children conceived, by planned use of different contraceptive techniques of contraception to prevent pregnancy.

Ortho Evra contraceptive transdermal birth control patch label update

Ortho Women?s Health & Urology, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., has updated the prescribing information for ORTHO EVRA (norelgestromin/ethinyl estradiol transdermal system) to include further epidemiologic data. – The U.S. Food and Drug Administration (FDA) approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills. VTE can lead to pulmonary embolism.

TV prescription drug ads minimize risk information

Prescription drug ads on television still do not present a fair balance of information, especially when it comes to the risk of side effects. – A new University of Georgia study finds that most of prescription drug ads on television still do not present a fair balance of information, especially when it comes to the risk of side effects.

New warning for nonoxynol 9 OTC contraceptives in US

Nonoxynol 9 or N9 in the widely available stand-alone contraceptive products do not protect against sexually transmitted diseases, including HIV infection. – The U.S. Food and Drug Administration (FDA) issued a final rule that requires that manufacturers of over-the-counter (OTC) stand-alone vaginal contraceptive and spermicidal products containing the chemical ingredient nonoxynol 9 (N9) include a warning that the chemical N9 does not provide protection against infection from HIV (the virus that causes AIDS) or other sexually transmitted diseases (STDs).

Health Newstrack